Abstract
In this work behavior of active pharmaceutical substances - methylprednisolone (in a form of methylprednisolone sodium succinate) in finished pharmaceutical dosage form - freeze dried powder for injections was examined. The goal was to evaluate the chemical stabilities of methylprednisolone sodium succinate packaged in dual chamber vial, as a specific container closure system. The effect of different parameters: temperature, moisture and light were monitored. USP method for assay was used to determine concentrations of methylprednisolone, as a sum of the concentration of methylprednisolone esters (17-hydrogen succinate and 21-hydrogen succinate) and free methylprednisolone. HPLC method was used for stability evaluation of active substance and related substances determination. Four main degradation products were noted. Temperature has a major impact on degradation process and appearance of 3 degradation products (impurities B, C and D), while the presence of light caused increasing content of impurity A. Identification of impurity B, C and D has been done using mass and NMR spectroscopy as well. All three substances are related substances of methylprednisolone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
